BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32735577)

  • 1. MISTIC: A prediction tool to reveal disease-relevant deleterious missense variants.
    Chennen K; Weber T; Lornage X; Kress A; Böhm J; Thompson J; Laporte J; Poch O
    PLoS One; 2020; 15(7):e0236962. PubMed ID: 32735577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Mendelian disease genes with the variant effect scoring tool.
    Carter H; Douville C; Stenson PD; Cooper DN; Karchin R
    BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S3. PubMed ID: 23819870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ClinPred: Prediction Tool to Identify Disease-Relevant Nonsynonymous Single-Nucleotide Variants.
    Alirezaie N; Kernohan KD; Hartley T; Majewski J; Hocking TD
    Am J Hum Genet; 2018 Oct; 103(4):474-483. PubMed ID: 30220433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PedMiner: a tool for linkage analysis-based identification of disease-associated variants using family based whole-exome sequencing data.
    Zhou J; Gao J; Zhang H; Zhao D; Li A; Iqbal F; Shi Q; Zhang Y
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32393981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mvPPT: A Highly Efficient and Sensitive Pathogenicity Prediction Tool for Missense Variants.
    Tong SY; Fan K; Zhou ZW; Liu LY; Zhang SQ; Fu Y; Wang GZ; Zhu Y; Yu YC
    Genomics Proteomics Bioinformatics; 2023 Apr; 21(2):414-426. PubMed ID: 35940520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global inference of disease-causing single nucleotide variants from exome sequencing data.
    Wu M; Chen T; Jiang R
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):468. PubMed ID: 28155632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A community-based resource for automatic exome variant-calling and annotation in Mendelian disorders.
    Mutarelli M; Marwah V; Rispoli R; Carrella D; Dharmalingam G; Oliva G; di Bernardo D
    BMC Genomics; 2014; 15 Suppl 3(Suppl 3):S5. PubMed ID: 25078076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CYSMA web server: An example of integrative tool for in silico analysis of missense variants identified in Mendelian disorders.
    Sasorith S; Baux D; Bergougnoux A; Paulet D; Lahure A; Bareil C; Taulan-Cadars M; Roux AF; Koenig M; Claustres M; Raynal C
    Hum Mutat; 2020 Feb; 41(2):375-386. PubMed ID: 31674704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretable prioritization of splice variants in diagnostic next-generation sequencing.
    Danis D; Jacobsen JOB; Carmody LC; Gargano MA; McMurry JA; Hegde A; Haendel MA; Valentini G; Smedley D; Robinson PN
    Am J Hum Genet; 2021 Sep; 108(9):1564-1577. PubMed ID: 34289339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of genetic variation in hypertrophic cardiomyopathy: comparison of computational tools to prioritize missense variants.
    Barbosa P; Ribeiro M; Carmo-Fonseca M; Fonseca A
    Front Cardiovasc Med; 2022; 9():975478. PubMed ID: 36061567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Improved Phenotype-Driven Tool for Rare Mendelian Variant Prioritization: Benchmarking Exomiser on Real Patient Whole-Exome Data.
    Cipriani V; Pontikos N; Arno G; Sergouniotis PI; Lenassi E; Thawong P; Danis D; Michaelides M; Webster AR; Moore AT; Robinson PN; Jacobsen JOB; Smedley D
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32340307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GenePy - a score for estimating gene pathogenicity in individuals using next-generation sequencing data.
    Mossotto E; Ashton JJ; O'Gorman L; Pengelly RJ; Beattie RM; MacArthur BD; Ennis S
    BMC Bioinformatics; 2019 May; 20(1):254. PubMed ID: 31096927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validity of phenotype-driven analysis software PhenoVar as a diagnostic aid for clinical geneticists in the interpretation of whole-exome sequencing data.
    Thuriot F; Buote C; Gravel E; Chénier S; Désilets V; Maranda B; Waters PJ; Jacques PE; Lévesque S
    Genet Med; 2018 Sep; 20(9):942-949. PubMed ID: 29388948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eDiVA-Classification and prioritization of pathogenic variants for clinical diagnostics.
    Bosio M; Drechsel O; Rahman R; Muyas F; Rabionet R; Bezdan D; Domenech Salgado L; Hor H; Schott JJ; Munell F; Colobran R; Macaya A; Estivill X; Ossowski S
    Hum Mutat; 2019 Jul; 40(7):865-878. PubMed ID: 31026367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning models for accurate prioritization of variants of uncertain significance.
    Mahecha D; Nuñez H; Lattig MC; Duitama J
    Hum Mutat; 2022 Apr; 43(4):449-460. PubMed ID: 35143088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies.
    Dong C; Wei P; Jian X; Gibbs R; Boerwinkle E; Wang K; Liu X
    Hum Mol Genet; 2015 Apr; 24(8):2125-37. PubMed ID: 25552646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting deleterious missense genetic variants via integrative supervised nonnegative matrix tri-factorization.
    Arani AA; Sehhati M; Tabatabaiefar MA
    Sci Rep; 2021 Dec; 11(1):23747. PubMed ID: 34887492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole exome sequencing in recurrent early pregnancy loss.
    Qiao Y; Wen J; Tang F; Martell S; Shomer N; Leung PC; Stephenson MD; Rajcan-Separovic E
    Mol Hum Reprod; 2016 May; 22(5):364-72. PubMed ID: 26826164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseases.
    Grunseich C; Sarkar N; Lu J; Owen M; Schindler A; Calabresi PA; Sumner CJ; Roda RH; Chaudhry V; Lloyd TE; Crawford TO; Subramony SH; Oh SJ; Richardson P; Tanji K; Kwan JY; Fischbeck KH; Mankodi A
    J Neurol Neurosurg Psychiatry; 2021 Nov; 92(11):1186-1196. PubMed ID: 34103343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The added value of WES reanalysis in the field of genetic diagnosis: lessons learned from 200 exomes in the Lebanese population.
    Jalkh N; Corbani S; Haidar Z; Hamdan N; Farah E; Abou Ghoch J; Ghosn R; Salem N; Fawaz A; Djambas Khayat C; Rajab M; Mourani C; Moukarzel A; Rassi S; Gerbaka B; Mansour H; Baassiri M; Dagher R; Breich D; Mégarbané A; Desvignes JP; Delague V; Mehawej C; Chouery E
    BMC Med Genomics; 2019 Jan; 12(1):11. PubMed ID: 30665423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.